Cancer BiologybioRxivPreprint
Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert tumor microenvironment and confers resistance to immunotherapy
J. Yan, Y. Chen, A. J. Patel…·P. Chi
This study shows that PRC2 inactivation in tumors creates an immune-desert microenvironment, leading to resistance to immunotherapy and suggests strategies to reverse this effect.
DOI 10.1101/2022.05.27.493507